Association of interleukin-17A rs2275913 polymorphism with rheumatoid arthritis susceptibility in Sudanese population. (May 2021)

• Record Type: Journal Article
• Authors: Osman, Rgda Mohamed; Noma, Mounkaila; Ahmed, Abdallah Elssir; Abdelbagi, Hanadi; Omer, Rihab Ali; Ali, Musab M; Mohammed Alameen, Ayman Ali; Edris, Ali Mahmoud; Muneer, Mohamed S.; Siddig, Omayma; Hassan, Rowa; Ahmed, Eiman Siddig; Hassan, Lamis Ahmed; Bakheet, Osama El Hadi; Ahmed, Ayman; Mohamed, Nouh Saad; Siddig, Emmanuel Edwar
• Is Part Of: SAGE open medicine. Volume 9(2021)
• Publication Date: 2021-05
• Subjects: Interleukin-17A -- rheumatoid arthritis -- Sudanese population; Medicine -- Periodicals; 610.5
• DOI: 10.1177/20503121211020207
• Languages: English
• ISSNs: 2050-3121

Abstract

Objectives: Rheumatoid arthritis is a chronic inflammatory autoimmune disease. This study aimed to determine the association of interleukin-17A-197G/A polymorphism with rheumatoid arthritis in Sudanese patients. Methods: A case–control study was conducted between March and December 2018. Clinical and demographic data of the study participants were collected and analyzed. Polymerase chain reaction restriction fragment length polymorphism molecular technique was done to investigate interleukin-17A-197G/A polymorphisms. All statistical tests were considered statistically significant when p < 0.05. Results: The study population included 266 participants aged between 1 and 85 years, with an average of 40 years, classified into 85 (31.2%) cases (mean age 48.5 ± 11.3 years), and 181 (68.8%) controls (mean age 35.3 ± 15.9 years). The interleukin-17A homozygote AA genotype was more frequent among the control group compared to the case group; 95 (52.5%) and 7 (8.2%), respectively. The homozygote GG and the heterozygote AG genotypes were proportionally not different among the cases and control groups; 13 (54.2%) and 11 (45.8%), and 65 (46.4%) and 75 (53.6%), respectively. According to the distribution of interleukin-17A genotypes, a statistically significant difference was observed among cases with the interleukin-17A AA and AG genotypes, p values 0.001 and 0.004, respectively. For the association interleukin-17A genotypes and family history a negatively significant association was reported (95% confidence interval, –0.219, p value = 0.001). There was also a negatively significant association of interleukin-17A genotypes and anti-cyclic citrullinated peptide (95% confidence interval, −0.141, p value = 0.002). Conclusion: This study is the first study in Sudan established the association between interleukin-17A-197G/A (rs2275913) polymorphisms and susceptibly to rheumatoid arthritis. These findings appeal for further research in Sudan to investigate the exact role of IL-17A in immunopathology and disease severity among Sudanese rheumatoid arthritis